Published in Circulation on November 17, 2003
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol (2011) 3.00
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol (2012) 2.18
Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls. Circ Arrhythm Electrophysiol (2014) 1.44
Arrhythmia risk stratification based on QT interval instability: an intracardiac electrocardiogram study. Heart Rhythm (2013) 1.42
The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J (2008) 1.17
Accuracy of noninvasive ejection fraction measurement in a large community-based clinic. Clin Med Res (2005) 0.97
Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol (2005) 0.95
Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease. J Am Heart Assoc (2012) 0.93
Sudden Cardiac Risk Stratification with Electrocardiographic Indices - A Review on Computational Processing, Technology Transfer, and Scientific Evidence. Front Physiol (2016) 0.93
Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease. Genet Med (2008) 0.92
Comparison and co-relation of invasive and noninvasive methods of ejection fraction measurement. J Natl Med Assoc (2007) 0.89
Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol (2014) 0.87
Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures. World J Cardiol (2014) 0.85
Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis. BMC Cardiovasc Disord (2009) 0.82
T-wave alternans testing for ventricular arrhythmias. Prog Cardiovasc Dis (2008) 0.81
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy. J Am Heart Assoc (2015) 0.79
Risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy. Indian Pacing Electrophysiol J (2005) 0.79
Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol (2014) 0.78
Current developments in microvolt T-wave alternans. Indian Pacing Electrophysiol J (2006) 0.78
A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J (2013) 0.78
Clinical significance of microvolt T-wave alternans. Herzschrittmacherther Elektrophysiol (2007) 0.78
Electrocardiographic Abnormalities and QTc Interval in Patients Undergoing Hemodialysis. PLoS One (2016) 0.77
Ventricular repolarization measures for arrhythmic risk stratification. World J Cardiol (2016) 0.76
Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy. J Vet Intern Med (2016) 0.75
Case scenario about TEE: Patient with dilated cardiomyopathy undergoing laparoscopic cholecystectomy. Pak J Med Sci (2013) 0.75
Usefulness of microvolt T-wave alternans testing in the assessment of all-cause mortality and life-threatening ventricular arrhythmia risk in patients with left ventricular dysfunction. Arch Med Sci (2014) 0.75
Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy. Hosp Pract (1995) (2010) 0.75
Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death. Europace (2016) 0.75
[Microvolt T-wave alternans. Ischemic vs. nonischemic dilated cardiomyopathy]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Predictors of serious arrhythmic events in patients with nonischemic heart failure. J Interv Card Electrophysiol (2016) 0.75
Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future. Circulation (2017) 0.75
Socio-economic analysis of cardiac resynchronization therapy. J Interv Card Electrophysiol (2007) 0.75
[Dilated cardiomyopathy]. Herzschrittmacherther Elektrophysiol (2012) 0.75
[Long term electrocardiography (Holter monitoring)]. Herzschrittmacherther Elektrophysiol (2008) 0.75
[Nonischemic dilated cardiomyopathy. Parameters of autonomic tone]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol (2009) 9.27
German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med (2007) 7.21
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 3.50
Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med (2006) 2.84
Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med (2012) 2.82
Athlete's heart or hypertrophic cardiomyopathy? Clin Res Cardiol (2008) 2.32
Reduction of mortality in community-acquired pneumonia after implementing standardized care bundles in the emergency department. Eur J Emerg Med (2014) 2.23
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor. Clin Chem (2004) 2.23
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2005) 2.11
Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol (2012) 2.05
Patients with syncope in a German emergency department: description of patients and processes. Dtsch Arztebl Int (2012) 1.93
The prevalence and prognostic significance of near syncope and syncope: a prospective study of 395 cases in an emergency department (the SPEED study). Dtsch Arztebl Int (2014) 1.76
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2. Circulation (2004) 1.73
Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol (2009) 1.71
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure. Eur J Heart Fail (2011) 1.70
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2011) 1.63
The German multicenter, randomized, partially blinded, prospective trial of acupuncture for chronic low-back pain: a preliminary report on the rationale and design of the trial. J Altern Complement Med (2003) 1.56
Method for aortic wall strain measurement with three-dimensional ultrasound speckle tracking and fitted finite element analysis. Ann Thorac Surg (2013) 1.56
QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart (2007) 1.55
Heart rate variability in patients with cardiac hypertrophy--relation to left ventricular mass and etiology. Am Heart J (2006) 1.55
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol (2002) 1.53
Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. J Am Coll Cardiol (2003) 1.52
Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab (2003) 1.46
Sepsis-induced urinary concentration defect is related to nitric oxide-dependent inactivation of TonEBP/NFAT5, which downregulates renal medullary solute transport proteins and aquaporin-2. Crit Care Med (2012) 1.46
Transporting clinical tools to new settings: cultural adaptation and validation of the Emergency Severity Index in German. Ann Emerg Med (2010) 1.44
The Interdisciplinary Management of Acute Chest Pain. Dtsch Arztebl Int (2015) 1.44
Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology (2007) 1.42
High-sensitivity troponin assays and clinical decisions. Ann Clin Biochem (2012) 1.42
Non-compaction cardiomyopathy in an adult with hereditary spherocytosis. Eur J Heart Fail (2006) 1.41
Minimal current intensity to elicit an evoked motor response cannot discern between needle-nerve contact and intraneural needle insertion. Anesth Analg (2014) 1.41
[The effectiveness of radiation treatment in comparison with extracorporeal shockwave therapy (ESWT) in supraspinatus tendon syndrome]. Strahlenther Onkol (2002) 1.40
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. Rev Esp Cardiol (Engl Ed) (2015) 1.39
Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet (2010) 1.37
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab (2004) 1.35
Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors. Clin Gastroenterol Hepatol (2008) 1.27
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol (2005) 1.23
Comparison of Web-versus classroom-based basic ultrasonographic and EFAST training in 2 European hospitals. Ann Emerg Med (2010) 1.15
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. Basic Res Cardiol (2008) 1.12
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer. J Clin Oncol (2010) 1.11
Magnetic resonance imaging in pericardial diseases. Indications and diagnostic value. Herz (2006) 1.11
Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs (2005) 1.10
Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest (2005) 1.09
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab (2015) 1.07
Osteoprotegerin gene polymorphisms in men with coronary artery disease. J Clin Endocrinol Metab (2004) 1.02
The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly (2007) 1.02
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial. J Clin Endocrinol Metab (2012) 1.00
Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol (2003) 0.99
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol (2011) 0.98
New definition of myocardial infarction: impact on long-term mortality. Am J Med (2008) 0.98
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgaris. J Invest Dermatol (2009) 0.98
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR. J Periodontol (2002) 0.98
Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol (2006) 0.97
Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to inflammation and cardiac function. Biochem Biophys Res Commun (2005) 0.96
Management strategies in pericardial emergencies. Herz (2006) 0.96
Right ventricular cardiac myxoma. Diagnostic usefulness of cardiac magnetic resonance imaging. Herz (2005) 0.95
A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Mol Genet Metab (2008) 0.95
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure. Herz (2002) 0.94
IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol (2008) 0.94
Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail Rev (2013) 0.93
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93
Prevalence of potential noninvasive arrhythmia risk predictors in healthy, middle-aged persons. Ann Noninvasive Electrocardiol (2003) 0.93
Parvovirus B19 genome in endomyocardial biopsy specimen. Circulation (2004) 0.93
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival. Neuroendocrinology (2016) 0.92
A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J (2013) 0.92
Accuracy of chest radiographs in the emergency diagnosis of heart failure. Eur Radiol (2008) 0.91
Novel point mutations in the mitochondrial DNA detected in patients with dilated cardiomyopathy by screening the whole mitochondrial genome. Biochem Biophys Res Commun (2004) 0.91
Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J Periodontol (2007) 0.90
Additional diagnostic and prognostic value of copeptin ultra-sensitive for diagnosis of non-ST-elevation myocardial infarction in older patients presenting to the emergency department. Clin Chem Lab Med (2013) 0.90
A 3-hour diagnostic algorithm for non-ST-elevation myocardial infarction using high-sensitivity cardiac troponin T in unselected older patients presenting to the emergency department. J Am Med Dir Assoc (2013) 0.90
Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol (2003) 0.90
Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. Int J Cardiol (2011) 0.89
Optimal multistage designs--a general framework for efficient genome-wide association studies. Biostatistics (2008) 0.89
Sudden cardiac death in dilated cardiomyopathy -- therapeutic options. Herz (2002) 0.89
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases]. Kardiol Pol (2015) 0.89
Correlation between age, emergency department length of stay and hospital admission rate in emergency department patients aged ≥70 years. Gerontology (2012) 0.89
Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Pacing Clin Electrophysiol (2006) 0.89
Conference on clinical use of troponin T high sensitive (TnThs) on September 8, 2009 at the airport conference center, Frankfurt/Main. Clin Lab (2010) 0.89
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet (2012) 0.88
An overview of statistical approaches for adaptive designs and design modifications. Biom J (2006) 0.88
Early detection of non-ST-elevation myocardial infarction in geriatric patients by a new high-sensitive cardiac troponin T assay. Aging Clin Exp Res (2011) 0.88
Severity illness scoring systems for early identification and prediction of in-hospital mortality in patients with suspected sepsis presenting to the emergency department. Wien Klin Wochenschr (2013) 0.88
Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Cardiovasc Pathol (2007) 0.88
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev (2013) 0.88
Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol (2003) 0.87
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency". Can J Physiol Pharmacol (2011) 0.87
Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. Clin Endocrinol (Oxf) (2004) 0.87
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol (2002) 0.87
Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria. Apoptosis (2008) 0.86
Recurrent pericarditis: mysterious or not so mysterious? Eur Heart J (2005) 0.86
Molecular mechanisms involved in atherosclerosis. Herz (2002) 0.86